Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 4,120 GBp
Change Today +36.00 / 0.88%
Volume 2.3M
As of 11:35 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Pascal Soriot

Chief Executive Officer, Executive Director and Member of Disclosure Committee,AstraZeneca PLC
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 8 different industries.

See Board Relationships
563,507,000 GBP
As of Fiscal Year 2014

Background*

Mr. Pascal Soriot has been the Chief Executive Officer at AstraZeneca PLC since October 1, 2012. Mr. Soriot served as the Chief Operating Officer of Roche Pharma AG from 2010 to September 1, 2012. He served as the Chief Operating Officer of Roche Pharmaceuticals at Roche Diabetes Care AG. He served as the Chief Operating Officer of Pharmaceuticals at Roche Holding AG since January 1, 2010 and served as its Head of Pharma Medicines. He served as the Chief Executive Officer ...

Read Full Background

Corporate Headquarters*

2 Kingdom Street
London, Greater London W2 6BD

United Kingdom

Phone: 44 20 7604 8000
Fax: 44 20 7604 8151

Board Members Memberships*

2012-Present
Chief Executive Officer, Executive Director and Member of Disclosure Committee

Education*

Doctorate
Ecole Nationale Vtrinaire at Maisons-Alfort
MBA
Groupe HEC

Other Affiliations*

Annual Compensation*

Salary1,133,000 GBP
Bonus1,926,000 GBP
Total Annual Compensation3,059,000 GBP

Stock Options*

All Other Compensation448,000 GBP

Total Compensation*

Total Annual Cash Compensation3,507,000 GBP
Total Short Term Compensation3,059,000 GBP
Other Long Term Compensation448,000 GBP
Total Calculated Compensation3,507,000 GBP
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AZN:LN 4,120.00 GBp +36.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
$1.4M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.4M
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.9M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.